Skip to content
Screener

The Cooper Companies, Inc. COO Office and surgical — Net Sales

Other product segments

Toric and multifocal
$364.9M+11.1%
Sphere, other
$358.6M+5.1%
Fertility
$143.8M+13.3%

Similar metrics at other companies

Enovis logo
ENOVSurgical — Net Sales
$294.53M+7.5%
Edwards Lifesciences logo
EWSurgical — Net Sales
$284.1M
MiMedx Group logo
MDXGSurgical — Net Sales
$39.3M+15.1%
AVN
AVNSSurgical pain and recovery — Net Sales
$21.8M-11.0%
Medtronic logo
MDTMedical Surgical — Net Sales
$2.39B+8.0%
Medline, Inc. logo
MDLNSurgical Solutions — Net Sales
$1.64B+8.7%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.3B+5.2%
Enterprise value$17.22B+7.7%
P/E60.6×+27.3×
P/S3.4×0.0×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Periods Ended April 30, / (In millions)Three Months / 2026Three Months / 2025Six Months / 2026Six Months / 2025
Toric and multifocal$364.9$328.4$716.1$647.8
Sphere, other358.6341.2702.5667.9
Total CooperVision net sales$723.5$669.6$1,418.6$1,315.7
CooperSurgical net sales by category:
Office and surgical$214.2$205.8$416.6$404.7
Fertility143.8126.9270.4246.6
Total CooperSurgical net sales358.0332.7687.0651.3
Total net sales$1,081.5$1,002.3$2,105.6$1,967.0

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s office and surgical — net sales?
The Cooper Companies, Inc. (COO) reported office and surgical — net sales of $214.2M in Q1 2026.
How has The Cooper Companies, Inc.'s office and surgical — net sales changed year-over-year?
The Cooper Companies, Inc.'s office and surgical — net sales increased by 4.1% year-over-year, from $205.8M to $214.2M.
What is the long-term trend for The Cooper Companies, Inc.'s office and surgical — net sales?
Over 3 years (2022 to 2025), The Cooper Companies, Inc.'s office and surgical — net sales has grown at a 9.2% compound annual growth rate (CAGR), from $633.6M to $824M.
What does office and surgical — net sales mean?
This metric represents the total revenue generated from the sale of products and services within the office and surgical segment. It reflects the company's ability to monetize specialized medical equipment and surgical supplies sold directly to healthcare providers and clinical facilities. Growth in this area indicates successful market penetration and demand for the company's surgical portfolio.

Ask your AI about The Cooper Companies, Inc.'s office and surgical — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude